A new research suggests that an advanced nanoemulsion form of vitamin D may play a pivotal role in improving core symptoms of Autism Spectrum Disorder (ASD) in young children.
Autism spectrum disorder is a developmental condition that impacts communication, social interactions, and behaviour. It typically appears in early childhood, with symptoms varying widely from mild to severe.
In a 6-month study involving 80 children aged 3 to 6 years who were diagnosed with ASD, researchers looked at the effects of two types of vitamin D3 supplements: a regular oral dose and a special nanoemulsion. The nanoemulsion, designed to boost absorption and bioavailability in the body, led to significantly better outcomes in social IQ, language skills, and autism severity scores than the conventional supplement.
Also Read | Can vitamin D slow down ageing? New study says yes
To assess the improvements, researchers used validated tools such as the Childhood Autism Rating Scale (CARS), the Vineland Adaptive Behaviour Scale, and the Preschool Language Scale. The children in the nanoemulsion group showed marked gains in receptive and expressive language, adaptive behaviour, and social functioning. Those administered the standard supplement did not show many changes, except for improved blood vitamin D levels.
These findings align with previous studies suggesting that vitamin D supports neurodevelopment by regulating neurotransmitters like serotonin, reducing inflammation, and protecting neurons from oxidative stress, all of which are believed to influence autism symptoms.
The findings are detailed in a peer-reviewed study titled “Improved core manifestations of autism following supplementation with vitamin D3-loaded nanoemulsion,” published in Nutrients.
